Skip to main content
BCRX logo
BCRX
(NASDAQ)
BioCryst Pharmaceuticals, Inc.
$8.70-- (--)
Loading... - Market loading

BioCryst Pharmaceuticals (BCRX) Stock Price & Financial Analysis

BioCryst Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.10 - $8.64
52-Week High$11.23
52-Week Low$6.00
Open$8.21
Volume3.77M
Average Volume (3M)4.45M
Market Cap1.86B
Shares Outstanding219.26M
P/E Ratio (TTM)7.04
Price to Sales (P/S)2.12
Price to Book (P/B)-15.59
EV/EBITDA6.41
Revenue (TTM)874.84M
Net Income (TTM)263.86M
Free Cash Flow (TTM)328.98M
EPS (TTM)$1.21
Profit Margin30.16%
Operating Margin38.98%
50-Day MA$9.05
200-Day MA$7.92
52-Week Change-23.41%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BioCryst Pharmaceuticals

What is the current stock price for BCRX?

As of the latest trading session, BCRX stock trades at $8.50. The 52-week range is $6.00–$11.23, with a day range of $8.10–$8.63.

What is the P/E ratio for BCRX?

BioCryst Pharmaceuticals's trailing P/E ratio is 7.0, meaning investors pay $7.0 for every $1 of annual earnings.

Does BCRX pay dividends?

BioCryst Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BCRX?

Analyst ratings and recommendations for BCRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BCRX?

BioCryst Pharmaceuticals's market capitalization is $1.86B, classifying it as a small-cap company..